Loading chat...
DE HB61
Bill
Status
6/19/2019
Primary Sponsor
Paul Baumbach
Click for details
AI Summary
-
Adds 18 new benzodiazepine drugs by name to Schedule IV of Delaware's Uniform Controlled Substances Act, including clonazolam, etizolam, flualprazolam, and flubromazolam.
-
Expands Schedule IV to include a blanket category covering "any material, compound, mixture, or preparation that contains benzodiazepine" to capture all current and future benzodiazepine drugs regardless of FDA approval status.
-
Lists 32 specific benzodiazepine substances in Schedule IV, including both federally approved drugs (alprazolam, diazepam, lorazepam) and non-approved synthetic variants.
-
Allows the Secretary to except compounds containing benzodiazepines from regulation if they contain non-depressant active ingredients in combinations that eliminate abuse potential.
-
Removes flunitrazepam from its previous individual listing and incorporates it into the broader benzodiazepine category added to Schedule IV.
Legislative Description
An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.
Last Action
Signed by Governor
6/19/2019